SM
Publications
58
Views
15,214
Downloads
3,169
Supervised works
1
Items per page
1 - 58 of 58
Title Published in Access level OA Policy Year Views Downloads
Complete response of a metastatic microsatellite-stable gastric cancer after neoadjuvant chemoimmunotherapy : should we still operate ? A case report and review of the literatureFrontiers in oncology
accessLevelPublic
2024 22 19
Cancer de l’œsophage : standards et innovations du traitement multidisciplinaireRevue médicale suisse
accessLevelPublic
2023 67 60
Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (ChangeQol Study)BMJ open
accessLevelPublic
2023 118 95
Laparoscopic for advanced gastric cancer—minimally invasive for maximal results?Translational gastroenterology and hepatology
accessLevelPublic
2022 363 69
Implementation and validation of a competency assessment tool for laparoscopic cholecystectomySurgical endoscopy and other interventional techniques
accessLevelPublic
2022 138 60
Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL scoreBritish journal of surgery
accessLevelPublic
2022 112 79
Assessment of predictors of early postoperative complications after primary robotically assisted Roux-en-Y gastric bypass: a multicenter, retrospective cohort studySurgical endoscopy
accessLevelPublic
2022 144 58
Therapieoptionen beim oligometastasierten MagenkarzinomDer Chirurg
accessLevelPublic
2021 288 117
Blood-based multi-cancer detection using a novel variant calling assay (DEEPGENTM): early clinical resultsCancers
accessLevelPublic
2021 203 69
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus studyBritish journal of surgery
accessLevelRestricted
2021 256 0
Impact of nonalcoholic steatohepatitis on the outcome of patients undergoing roux-en-y gastric bypass surgery: a propensity score-matched analysisObesity Surgery
accessLevelPublic
2021 189 77
Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort studyEuropean journal of surgical oncology
accessLevelRestricted
2021 236 0
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACOBMC cancer
accessLevelPublic
2021 298 72
Esophageal cancer surgery: review of complications and their managementAnnals of the New York Academy of Sciences
accessLevelRestricted
2020 201 1
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen ÜbergangsDer Chirurg
accessLevelRestricted
2020 184 1
Quand référer un patient en vue d'un traitement chirurgical de l'obésitéRevue médicale suisse
accessLevelPublic
2020 362 179
Cancer de l'œsophage et de la jonction oesogastrique: prise en charge et traitement multidisciplinaireRevue médicale suisse
accessLevelPublic
2020 440 285
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAVBMC Cancer
accessLevelPublic
2020 178 72
Fit-for-discharge criteria after esophagectomy: an international expert delphi consensusDiseases of the Esophagus
accessLevelRestricted
2020 191 1
Current surgical treatment standards for esophageal and esophagogastric junction cancerAnnals of the New York Academy of Sciences
accessLevelRestricted
2020 178 1
Incidence and grading of complications after gastrectomy for cancer using the GASTRODATA registry: a european retrospective observational studyAnnals of Surgery
accessLevelRestricted
2020 180 1
Development and Validation of a Predictive Model for Internal Hernia after Roux-en-Y Gastric Bypass in a Multicentric Retrospective Cohort: The Swirl, Weight Excess Loss, Liquid ScoreAnnals of Surgery
accessLevelRestricted
2020 440 2
International Variation in Surgical Practices in Units Performing Oesophagectomy for Oesophageal Cancer: A Unit Survey from the Oesophago-Gastric Anastomosis Audit (OGAA)World journal of surgery
accessLevelRestricted
2019 323 13
Perioperative chemotherapy for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialThe Lancet
accessLevelRestricted
2019 349 1
Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literatureUpdates in Surgery
accessLevelRestricted
2019 311 2
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen ÜbergangsZeitschrift für Gastroenterologie
accessLevelRestricted
2019 347 0
Delay in initiation adjuvant S-1 monotherapy for gastric cancer: important prognostic factorTranslational Gastroenterology and Hepatology
accessLevelPublic
2019 280 130
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinomaEuropean Journal of Cancer
accessLevelRestricted
2019 232 1
S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ÖsophagusZeitschrift für Gastroenterologie
accessLevelPublic
2019 277 292
International consensus on a complications list after gastrectomy for cancerGastric cancer
accessLevelRestricted
2019 271 0
Laparoscopic Surgery for Gastric Cancer: The European Point of ViewJournal of Oncology
accessLevelPublic
2019 294 115
Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?Histopathology
accessLevelRestricted
2019 377 1
The role of surgery in advanced disease for esophageal and junctional cancerBest Practice & Research: Clinical Gastroenterology
accessLevelRestricted
2018 306 1
Cancer de l'estomac : prise en charge et traitement multidisciplinaireRevue médicale suisse
accessLevelPublic
2018 503 729
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)European journal of cancer
accessLevelRestricted
2018 249 0
Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiationAnnals of the New York Academy of Sciences
accessLevelRestricted
2018 307 0
Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical reviewCritical reviews in oncology/hematology
accessLevelRestricted
2018 274 0
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACOPleura and Peritoneum
accessLevelPublic
2018 329 226
Chirurgische Strategie bei Frühkarzinomen des ÖsophagusDer Chirurg
accessLevelRestricted
2018 290 0
Multimodal treatment in locally advanced gastric cancerUpdates in Surgery
accessLevelRestricted
2018 313 1
Die Fremdkörperingestion – eine seltene Ursache persistierender, unklarer abdomineller SchmerzenDeutsche Medizinische Wochenschrift
accessLevelRestricted
2018 295 0
Cancer of the gastroesophageal junction: a diagnosis, classification, and management reviewAnnals of the New York Academy of Sciences
accessLevelRestricted
2018 322 0
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survivalGastric cancer
accessLevelPublic
2017 100 58
Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched studyEuropean journal of surgical oncology
accessLevelRestricted
2017 285 0
Gastric cancer treatment in the world: GermanyTranslational Gastroenterology and Hepatology
accessLevelRestricted
2017 572 1
Therapeutisches Vorgehen beim oligometastasierten Magen- und ÖsophaguskarzinomDer Chirurg
accessLevelRestricted
2017 315 0
Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-GastrectomyWorld journal of surgery
accessLevelRestricted
2017 126 0
Current and future treatment options for esophageal cancer in the elderlyExpert opinion on pharmacotherapy
accessLevelRestricted
2017 317 0
Preoperative staging of nodal status in gastric cancerTranslational gastroenterology and hepatology
accessLevelRestricted
2017 643 0
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 TrialJAMA oncology
accessLevelRestricted
2017 166 0
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGIBMC cancer
accessLevelPublic
2017 326 78
Obstipation bei Patienten mit nicht-heilbarer Krebserkrankung: Empfehlungen der S3-Leitlinie PalliativmedizinDeutsche medizinische Wochenschrift
accessLevelRestricted
2016 261 0
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus ConferenceGastric cancer
accessLevelPublic
2016 164 73
Resektion beim fortgeschrittenen Adenokarzinom des Magens und des Ösophagus : Erweiterung der IndikationDer Chirurg
accessLevelRestricted
2016 236 0
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinomaOncoimmunology
accessLevelPublic
2016 119 56
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trialLancet. Oncology
accessLevelRestricted
2016 275 0
Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care)European journal of surgical oncology
accessLevelRestricted
2016 152 0
Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?Gastric cancer
accessLevelPublic
2016 120 73
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack